Clinical trial
Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases
NCT07361094
Study timeline
Study start (actual)2025-11-06Date precision: day
Registry last updated2026-01-22
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsed/Refractory Systemic Sclerosisunresolved
Relapsed/Refractory sjögren's Syndromeunresolved
Relapsed/Refractory Multiple Sclerosisunresolved
Interventions
Sponsors & collaborators
Beijing Boren Hospitallead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07361094 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.